Persistent use of a single disease-modifying therapy (DMT) over a three-year period was low among people with relapsing forms of multiple sclerosis (MS), a U.S. study found. DMT discontinuations or switches were initiated in some cases by prescribers, specialty pharmacists, or patients for reasons that included treatment side…

People with high levels of free vitamin D in circulation before the age of 20 have a lower risk of developing multiple sclerosis (MS) later in life, a new study suggests. A significantly lower risk was also observed among people who, at ages 30–39, had elevated levels of a…

Last weekend was a busy one. On Friday, I had to drop my eldest son at school at 5:30 a.m. for a field trip and then pick him up at 11 p.m. A nap wasn’t in the cards, I’m sad to say, and at some point in the evening, I…

In my cooking days, I always had a stock simmering away. Nothing was wasted. What had been frugality spurred on by self-imposed poverty — first as a student, then in the struggling life of a garret writer — later became the general political point of not wasting resources. It hurts…

It may sound like a joke or a scam, but there’s a nonprofit organization called RIP Medical Debt that might pay off your medical debt. Yep, all of it. According to the organization’s website, RIP Medical Debt has paid off more than $6.7 billion of other people’s medical bills…

People with progressive forms of multiple sclerosis (MS) and those with greater MS-related disability have a significantly greater risk of serious infections relative to people without the disease, according to a population-based study in Sweden. Notably, these associations were observed regardless of the use of disease-modifying therapies, many…

Genetic variants that contribute to a high body mass index (BMI) during childhood are associated with an increased risk of developing multiple sclerosis (MS), a study found. The relationship is likely influenced by the fact that a higher BMI in childhood is linked to obesity in adulthood and a “longer…

ABX-002, an experimental treatment for multiple sclerosis (MS) being developed by Autobahn Therapeutics, promoted the restoration of the myelin sheath in preclinical models of the disease, new data show. The research, which specifically tested an analog of ABX-002 called LL-341070, will be presented by Autobahn’s academic collaborators at…

Aquatic exercise is used less often by people with multiple sclerosis (MS) than land-based exercise, but it’s generally well liked by those who use it, a patient survey found. A lack of pool access and associated expenses remain significant barriers to aquatic exercise. The team also found that exercise…